2,7-Methano-1H-3-benzazonin-9-ol,2,3,4,5,6,7-hexahydro-3,7,12-trimethyl-, hydrobromide, (2a,7a,12R*)- (9CI) (28105-02-4)

Identification
Name:	2,7-Methano-1H-3-benzazonin-9-ol,2,3,4,5,6,7-hexahydro-3,7,12-trimethyl-, hydrobromide, (2a,7a,12R*)- (9CI)
Synonyms:	2,7-Methano-1H-3-benzazonin-9-ol,2,3,4,5,6,7-hexahydro-3,7a,12-trimethyl-, hydrobromide, stereoisomer (8CI)
CAS:	28105-02-4
Molecular Formula:	C16H23 N O . Br H
Molecular Weight:	326.2719
InChI:	InChI=1/C16H23NO.BrH/c1-11-15-9-12-5-6-13(18)10-14(12)16(11,2)7-4-8-17(15)3;/h5-6,10-11,15,18H,4,7-9H2,1-3H3;1H/t11-,15-,16+;/m0./s1
Molecular Structure:
Properties
Flash Point:	166.3°C
Boiling Point:	363.2°C at 760 mmHg
Flash Point:	166.3°C
Safety Data

Other Product

2,7-Methano-1H-3-benzazonin-9-ol,2,3,4,5,6,7-hexahydro-3,7,12-trimethyl-, hydrobromide, [2R-(2a,7a,12R*)]- (9CI)
2,7-Methano-1H-3-benzazonin-9-ol, 2,3,4,5,6,7-hexahydro-3-(cyclopropylmethyl)-7,12-dimethyl-, hydrochloride, (2R-(2-alpha,7-alpha,12S*))-
2,7-Methano-1H-3-benzazonin-9-ol, 2,3,4,5,6,7-hexahydro-7,12-dimethyl-3-(3-methyl-2-butenyl)-, hydrochloride, (2R-(2-alpha,7-alpha,12S*))-
(1S,6R,12R)-1,4,12-trimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonin-10-ol hydrobromide
2,7-Methano-1H-3-benzazonin-9-ol,2,3,4,5,6,7-hexahydro-3,7-dimethyl-, hydrobromide (1:1)
(2S,7S,12R)-7,12-dimethyl-3-(3-methylbut-2-en-1-yl)-2,3,4,5,6,7-hexahydro-1H-2,7-methano-3-benzazonin-9-ol hydrochloride
(2S,7S,12R)-3-(cyclopropylmethyl)-7,12-dimethyl-2,3,4,5,6,7-hexahydro-1H-2,7-methano-3-benzazonin-9-ol hydrochloride
2,6-Methano-3-benzazocin-11-ol,1,2,3,4,5,6-hexahydro-8-methoxy-6-methyl-3-(2-phenylethyl)-, hydrobromide, (2a,6a,11S*)- (9CI)
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-3-[2-(4-methoxyphenyl)ethyl]-6,11-dimethyl-,hydrobromide, (2a,6a,11R*)- (9CI)
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-, hydrobromide, [2R-(2a,6a,11S*)]- (9CI)
2,6-Methano-3-benzazocin-8-ol,1,2,3,4,5,6-hexahydro-3,6,11-trimethyl-, hydrobromide, [2R-(2a,6a,11R*)]- (9CI)
2-hydroxypropanoic acid - (1S,6R,12R)-4,12-dimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonin-10-ol (1:1)
2,6-Methano-3-benzazocin-8-ol,6,11-diethyl-1,2,3,4,5,6-hexahydro-3-(2-phenylethyl)-, hydrobromide, (2a,6a,11R*)- (9CI)
Spiro[2-cyclohexene-1,2'(1'H)-cyclopenta[de]naphthacene]-9'-carboxamide,7',7'a,8',11',11'a,12'-hexahydro-5',6',7'a,10',11'a,12'-hexahydroxy-3'-methoxy-2,6,6-trimethyl-7',8'-dioxo-,(1R,7'aR,11'aR,12'R)-rel-(-)-
2,7-Methano-1H-cyclopentapyrazin-3(2H)-one,hexahydro-5-hydroxy-1-methyl-,(2-alpha-,4a-bta-,5-alpha-,7-alpha-,7a-bta-)-(9CI)
2,5-Methano-1H-benz[e]indol-7-ol,3-(2-cyclopropylethyl)-5-ethyl-2,3,3a,4,5,9b-hexahydro-
2,5-Methano-1H-benz[e]indol-7-ol,5-ethyl-2,3,3a,4,5,9b-hexahydro-3-(2-propenyl)-
2,5-Methano-1H-benz[e]indol-7-ol,3-(2-cyclopropylethyl)-2,3,3a,4,5,9b-hexahydro-5-methyl-
2,6-Methano-3-benzazocin-11-ol,1,2,3,4,5,6-hexahydro-8-methoxy-3,6,11-trimethyl-, hydrobromide, (2a,6a,11R*)- (9CI)
2-hydroxypropanoic acid - (1S,6R,12S)-1,4,12-trimethyl-2,3,4,5,6,7-hexahydro-1H-1,6-methano-4-benzazonin-10-ol (1:1)